Detailed price information for Satellos Bioscience Inc (MSCLF) from The Globe and Mail including charting and trades.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

One of the simplest, most over-studied organisms in the world is the C. elegans nematode. For 13 years, a project called ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Pulse Biosciences, Inc. (NASDAQ: PLSE) Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings ...

Welcome to Plus Therapeutics fourth quarter and full-year 2024 results conference call. Before we begin, we want to advise you that over the course of the call, including any question-and-answer ...

Soquelitinib is well-positioned as a first-in-class oral therapy that selectively inhibits ITK to modulate and control parallel signaling ... data from 16 patients in Cohort 1 and 10 patients ...

BioAtla is extending its runway beyond key clinical readouts in 1H 2026 by restructuring and realigning resources, which ...

Philip Taylor; Investor Relations; Pulse Biosciences Inc. Paul Laviolette; Co-Chairman of the Board, President, Chief Executive Officer; Pulse Biosciences Inc. Jon S ...

Frizzell D’Souza’s music doesn’t shout—it lingers. In this exclusive interview, the Mangaluru-born indie artist opens up ...

While cultural differences persist, similarities such as histories, climate, topography, and vegetation allow design ...